Asia-Pacific Cold Sore Treatment Market is Valued at USD 198.29 Million at a CAGR of 7.2% During the Forecast Period 2028

Asia-Pacific Cold Sore Treatment Market analysis report covers detailed value chain analysis of the market. The value chain analysis helps to analyze major upstream raw materials, major equipment's, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restraints for the market. It presents a comparative detailed analysis of all regional and player segments, offering readers a better knowledge of the areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.

Cold sore treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.2% in the forecast period of 2021 to 2028 and is expected to reach USD 198.29 million by 2027 from USD 116.71 million in 2020.

Rising prevalence of Herpes simplex virus (HSV) globally and proliferation in modes of transmission of HSV, growing technological advancement and development are the major drivers which propelled the demand of the market in the forecast period.

Cold sores or oral herpes are small blisters like abrasions that occur due to the infection caused by the Herpes simplex virus (HSV). Cold sores generally occur on the face, around the lips, chin, cheeks, and nostrils. They generally cause pain, itching before they burst. HSV is one of the most common viruses found to affect the global population and it is endemic throughout the world. Up to 90% of people around the world have at least one form of HSV.

Herpes Simplex Virus (HSV) generally infects the pediatric population worldwide, but according to WHO, people aged 30-49 are at higher risk now for catching the virus, and the prevalence of HSV increases with age. HSV has two types: HSV type-1, and HSV type-2. HSV-1 causes cold sores or oral herpes around lips, nostrils, and cheeks. While HSV-2 cause's genital herpes. HSV can be spread through the direct mode of transmission which includes oral contact inducing infection with oral herpes, from oral to skin surfaces that appear normal and when there are no symptoms present.

The cold sores treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Download Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-cold-sore-treatment-market

Asia-Pacific Cold sores treatment Market Scope and Market Size

The cold sore treatment market is categorized into six notable segments which are based on the strain type, therapeutics type, drug type, dosage type, end user and distribution channel.

On the basis of strain type, the cold sore treatment market is segmented into herpes simplex type-1 virus, and herpes simplex type-2 virus. In 2021, Herpes simplex type-1 virus (HSV), segment is dominating the market due to its rapidly increasing prevalence.

On the basis of therapeutics type, the cold sore treatment market is segmented into antiviral agents, analgesic agents, and others. In 2021, antiviral segment is expected to dominate the cold sore treatment market due to the increased count of infectious diseases caused by herpes simplex virus and enhanced product pipeline in antiviral agents are predicted to dominate the market.

On the basis of drug type, the cold sore treatment market is segmented into branded and generics. In 2021, generics is dominating the cold sore treatment market because it's very less expensive as compared to branded drugs, and due to the economical nature, and increased usage for the treatment of cold sores.

On the basis of dosage type, the cold sore treatment market is segmented into oral, topical, and others. In 2021, oral segment is expected to dominate the cold sore treatment market because of its ease of absorption and flexibility to accommodate various types of drugs.

On the basis of end user, the cold sore treatment market is segmented into hospitals, homecare, specialty clinics, and others. In 2021, homecare segment is dominating the market due to the ease in treatment at home and easy availability of drugs.

On the basis of distribution channel, the cold sore treatment market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, hospital pharmacy is expected to dominate the market due to the rise in access to cold sore medications and surge in number of prescriptions of cold sore medications on a daily basis are predicted to dominate the market.

Competitive Landscape and Cold sore treatment Market Share Analysis

Cold sore treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus related to Cold sore treatment market.

The major companies providing cold sore treatment are Merix Pharmaceutical Corp., GlaxoSmithKline plc, Amneal Pharmaceuticals LLC, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceutical Inc., U.S.A. (A subsidiary OF Glenmark Pharmaceuticals Ltd.), Zydus Pharmaceuticals, Inc.(A Subsidiary of Zydus Cadila), Cipla Inc., AiCuris, Ortho dermatologics' (a division of bausch health Companies Inc.), Foundation Consumer Healthcare, Squarex, Teva Pharmaceuticals USA, Inc. (a subsidiary of Teva Pharmaceutical Industries Ltd.), Aurobindo Pharma U.S.A. (A Subsidiary of Aurobindo Pharma), WOCKHARDT, Novartis AG, Jubilant Cadista (a subsidiary of Jubilant Life Sciences Limited), Hikma Pharmaceuticals PLC, Hetero Healthcare Limited, Apotex Inc., Avanir Pharmaceuticals, Inc., HRA Pharma, among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-cold-sore-treatment-market

Top Trending Report:-

https://postheaven.net/furi19xjk0
https://rollbol.com/blogs/1574155/Cystoscope-market-size-was-valued-at-USD-694-2-million
https://justpaste.it/bq9ym
https://www.pearltrees.com/rjgpt006/sbm-march/id64859663/item514236958
https://www.diigo.com/user/ryan40/b/666862221
https://baitk.com/read-blog/12950
https://www.zedlike.com/blogs/80116/Cystoscope-market-size-was-valued-at-USD-694-2-million
https://pastelink.net/7rn5sabf
https://marketresearch693615496.wordpress.com/2023/04/21/cystoscope-market-size-was-valued-at-usd-694-2-million-with-a-cagr-of-6-47-during-the-forecast-period-2028-4/
https://wignar.com/read-blog/16236
https://kyourc.com/read-blog/81794
https://rentry.co/m6hb2
https://www.spoke.com/topics/cystoscope-market-size-was-valued-at-usd-694-2-million-with-a-cagr-of-6-47-during-the-forecast-period-2028-644251a0fc32d3db28036434
https://zenwriting.net/6wrr645eke
https://paperpage.in/blogs/100107/Cystoscope-market-size-was-valued-at-USD-694-2-million
https://waoop.com/read-blog/63315
https://eyeball.blog/read-blog/15774
https://kadeum.com/blogs/53253/Cystoscope-market-size-was-valued-at-USD-694-2-million
https://writeablog.net/
https://www.tamaiaz.com/blogs/57152/Cystoscope-market-size-was-valued-at-USD-694-2-million
https://webyourself.eu/blogs/122303/Cystoscope-market-size-was-valued-at-USD-694-2-million
https://beyondher.mn.co/posts/35377430
https://dbmr006.blogspot.com/2023/04/dual-chamber-syringe-dcs-filling.html
https://www.tumblr.com/blog/rjgpt006
https://www.evernote.com/client/web?login=true#?an=true&n=2c225947-c86c-7c32-579e-bda8150edff6&
https://baskadia.com/post/5sa5
https://postheaven.net/
https://rollbol.com/blogs/1574195/Dual-Chamber-Syringe-DCS-Filling-Machine-Market-is-expected-to
https://justpaste.it/9ouug
https://www.pearltrees.com/rjgpt006/sbm-march/id64859663/item514239678
https://www.diigo.com/user/ryan40/b/666864131
https://baitk.com/read-blog/12951
https://www.zedlike.com/blogs/80130/Dual-Chamber-Syringe-DCS-Filling-Machine-Market-is-expected-to
https://pastelink.net/f1hg55co
https://marketresearch693615496.wordpress.com/2023/04/21/dual-chamber-syringe-dcs-filling-machine-market-is-expected-to-witness-huge-demand-at-cagr-of-8-02-by-2028-3/
https://wignar.com/read-blog/16248
https://kyourc.com/read-blog/81812
https://rentry.co/xxaio
https://www.spoke.com/topics/dual-chamber-syringe-dcs-filling-machine-market-is-expected-to-witness-huge-demand-at-cagr-of-8-02-by-2028-644256ee00339477e6004c61
https://zenwriting.net/s00mpowo0p
https://paperpage.in/blogs/100143/Dual-Chamber-Syringe-DCS-Filling-Machine-Market-is-expected-to
https://waoop.com/read-blog/63341
https://eyeball.blog/read-blog/15794
https://kadeum.com/blogs/53258/Dual-Chamber-Syringe-DCS-Filling-Machine-Market-is-expected-to
https://writeablog.net/7t790n30w0
https://www.tamaiaz.com/blogs/57195/Dual-Chamber-Syringe-DCS-Filling-Machine-Market-is-expected-to
https://webyourself.eu/blogs/122325/Dual-Chamber-Syringe-DCS-Filling-Machine-Market-is-expected-to
https://beyondher.mn.co/posts/35378227
https://dbmr006.blogspot.com/2023/04/healthcare-revenue-cycle-management.html
https://www.tumblr.com/blog/rjgpt006

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com

This release was published on openPR.